Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Non-Current Deferred Tax Liability (2016)

Historic Non-Current Deferred Tax Liability for Aptevo Therapeutics (APVO) over the last 2 years, with Q2 2016 value amounting to $15.8 million.

  • Aptevo Therapeutics' Non-Current Deferred Tax Liability changed N/A to $15.8 million in Q2 2016 from the same period last year, while for Jun 2016 it was $15.8 million, marking a year-over-year change of. This contributed to the annual value of $15.8 million for FY2015, which is N/A changed from last year.
  • Latest data reveals that Aptevo Therapeutics reported Non-Current Deferred Tax Liability of $15.8 million as of Q2 2016.
  • In the past 5 years, Aptevo Therapeutics' Non-Current Deferred Tax Liability ranged from a high of $15.8 million in Q4 2015 and a low of $15.8 million during Q4 2015